301 related articles for article (PubMed ID: 19816957)
1. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
[TBL] [Abstract][Full Text] [Related]
2. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116.
Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA
Radiother Oncol; 2010 Mar; 94(3):375-83. PubMed ID: 20344822
[TBL] [Abstract][Full Text] [Related]
3. Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.
Emlet DR; Gupta P; Holgado-Madruga M; Del Vecchio CA; Mitra SS; Han SY; Li G; Jensen KC; Vogel H; Xu LW; Skirboll SS; Wong AJ
Cancer Res; 2014 Feb; 74(4):1238-49. PubMed ID: 24366881
[TBL] [Abstract][Full Text] [Related]
4. Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo.
Peickert S; Waurig J; Dittfeld C; Dietrich A; Garbe Y; Kabus L; Baumann M; Grade M; Ried T; Kunz-Schughart LA
Lab Invest; 2012 Nov; 92(11):1607-22. PubMed ID: 22964855
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44
Kim J; Choi KW; Lee J; Lee J; Lee S; Sun R; Kim J
Int J Biol Sci; 2021; 17(7):1644-1659. PubMed ID: 33994850
[TBL] [Abstract][Full Text] [Related]
6. Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells.
Choi YJ; Park JH; Han JW; Kim E; Jae-Wook O; Lee SY; Kim JH; Gurunathan S
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973444
[TBL] [Abstract][Full Text] [Related]
7. Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.
Tiran V; Lindenmann J; Brcic L; Heitzer E; Stanzer S; Tabrizi-Wizsy NG; Stacher E; Stoeger H; Popper HH; Balic M; Dandachi N
Sci Rep; 2017 Aug; 7(1):10040. PubMed ID: 28855609
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.
Botchkina GI; Zuniga ES; Rowehl RH; Park R; Bhalla R; Bialkowska AB; Johnson F; Golub LM; Zhang Y; Ojima I; Shroyer KR
PLoS One; 2013; 8(9):e69884. PubMed ID: 24086245
[TBL] [Abstract][Full Text] [Related]
9. DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells.
Koshio J; Kagamu H; Nozaki K; Saida Y; Tanaka T; Shoji S; Igarashi N; Miura S; Okajima M; Watanabe S; Yoshizawa H; Narita I
Cancer Immunol Immunother; 2013 Oct; 62(10):1619-28. PubMed ID: 23974721
[TBL] [Abstract][Full Text] [Related]
10. Protein CD133 as a tumor stem cell marker.
Grabovenko FI; Kisil OV; Pavlova GV; Zvereva ME
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(6):113-120. PubMed ID: 36534632
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Cancer Stem Cells: Unraveling a Germline Connection.
Parte SC; Smolenkov A; Batra SK; Ratajczak MZ; Kakar SS
Stem Cells Dev; 2017 Dec; 26(24):1781-1803. PubMed ID: 29078734
[TBL] [Abstract][Full Text] [Related]
12. A metabolic signature of colon cancer initiating cells.
Chen KY; Liu X; Bu P; Lin CS; Rakhilin N; Locasale JW; Shen X
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():4759-62. PubMed ID: 25571056
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells in lung cancer: Evidence and controversies.
Alamgeer M; Peacock CD; Matsui W; Ganju V; Watkins DN
Respirology; 2013 Jul; 18(5):757-64. PubMed ID: 23586700
[TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts.
Boso D; Tognon M; Curtarello M; Minuzzo S; Piga I; Brillo V; Lazzarini E; Carlet J; Marra L; Trento C; Rasola A; Masgras I; Caporali L; Del Ben F; Brisotto G; Turetta M; Pastorelli R; Brunelli L; Navaglia F; Esposito G; Grassi A; Indraccolo S
J Exp Clin Cancer Res; 2023 Aug; 42(1):196. PubMed ID: 37550722
[TBL] [Abstract][Full Text] [Related]
15. Prospective identification of tumorigenic breast cancer cells.
Al-Hajj M; Wicha MS; Benito-Hernandez A; Morrison SJ; Clarke MF
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):3983-8. PubMed ID: 12629218
[TBL] [Abstract][Full Text] [Related]
16. Tracking the Routes of Cancer: The Microevolution of Cancer-Associated Fibroblasts.
Czyż J
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958453
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
[TBL] [Abstract][Full Text] [Related]
18. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
[TBL] [Abstract][Full Text] [Related]
19. CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.
Gao MQ; Choi YP; Kang S; Youn JH; Cho NH
Oncogene; 2010 May; 29(18):2672-80. PubMed ID: 20190812
[TBL] [Abstract][Full Text] [Related]
20. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
Lapidot T; Sirard C; Vormoor J; Murdoch B; Hoang T; Caceres-Cortes J; Minden M; Paterson B; Caligiuri MA; Dick JE
Nature; 1994 Feb; 367(6464):645-8. PubMed ID: 7509044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
